News / Taiwan / cnyes
SyncVision Reports 49% YoY Revenue Growth for August
Health Technology · Medical Specialties · cnyes · 2026-09-09
4155
SyncVision (4155) announced August revenue of NT$197 million, a 49.35% year-on-year increase, driven by strong demand in the medical device sector.
What Happened
Revenue Performance: SyncVision (4155) reported August revenue of NT$197 million, achieving a 49.35% year-on-year increase. The company also recorded a strong month-on-month growth of 29.08%.
Year-to-Date Results: Cumulative revenue for the first eight months of 2026 reached NT$1.173 billion, reflecting a year-to-date growth of 8.19%. This indicates steady operational progress in the medical device market.
Market Performance: The stock is currently trading at NT$14.1, with a 2.08% decline over the past five days. The stock's performance has been slightly weaker than the broader biotech and healthcare sector, with no clear short-term price trend.
Company Overview: SyncVision specializes in the manufacturing, distribution, and retail of medical devices and equipment. The company operates within the healthcare technology sector, focusing on medical solutions.